139 related articles for article (PubMed ID: 22612611)
1. Colorectal cancer in women: hormone replacement therapy and chemoprevention.
Barnes EL; Long MD
Climacteric; 2012 Jun; 15(3):250-5. PubMed ID: 22612611
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
3. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
5. Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.
Langer RD; Manson JE; Allison MA
Climacteric; 2012 Jun; 15(3):206-12. PubMed ID: 22612605
[TBL] [Abstract][Full Text] [Related]
6. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
Aubuchon M; Santoro N
Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment?
Solimando R; Bazzoli F; Ricciardiello L
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):555-68. PubMed ID: 22122771
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy in postmenopausal women.
Prelevic GM; Kocjan T; Markou A
Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
[TBL] [Abstract][Full Text] [Related]
11. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
12. Current trends in hormone replacement therapy: perceptions and usage.
Birkhäuser MH; Reinecke I
Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based assessment of the impact of the WHI on women's health.
Burger HG; MacLennan AH; Huang KE; Castelo-Branco C
Climacteric; 2012 Jun; 15(3):281-7. PubMed ID: 22612616
[TBL] [Abstract][Full Text] [Related]
14. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
15. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
Grimes DA; Lobo RA
Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
[TBL] [Abstract][Full Text] [Related]
17. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
18. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
19. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
[TBL] [Abstract][Full Text] [Related]
20. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
Haskell SG
J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
